期刊文献+

消化道恶性肿瘤患者手术前后贫血状况的临床研究 被引量:1

原文传递
导出
摘要 目的探讨消化道恶性肿瘤患者手术前后的贫血状况。方法调查统计消化道肿瘤患者手术前后贫血的发生率、贫血的程度、铁代谢状况等,观察贫血对癌性疲劳和生活质量的影响,观察手术对消化道肿瘤患者铁代谢的影响。结果与术前相比,术后消化道恶性肿瘤患者的红细胞计数、H b、血清铁及铁蛋白水平下降,缺铁性贫血发病率上升,胃癌术后贫血发生率稍高,结、直肠癌术前贫血的发生率高于上消化道肿瘤。贫血患者术前疲劳评分较未出现贫血患者降低不明显,术后疲劳评分多有不同程度的减低,患者的生活质量有不同程度的减低。结论消化道恶性肿瘤患者手术前后常见轻中度贫血及缺铁性贫血,且临床对于肿瘤相关性贫血的治疗重视程度不够,需要更多规范的研究指导临床。
出处 《中国城乡企业卫生》 2013年第3期18-20,共3页 Chinese Journal of Urban and Rural Enterprise Hygiene
  • 相关文献

参考文献8

  • 1Ludwig H, Van Belle S, Barrett-Lee P, et al.The European Cancer Anaemia Survey (ECAS):a large, multinational, prospective survey defining the prevalence, incidence, and treatment of anaemia in can- cer patients[J]. Eur J Cancer, 2004, 40( 15 ) : 2293-2306.
  • 2Ho CH, Chau WK, Hsu HC, et al.Predictive risk factors and preva- lence of malignancy in patients with iron deficiency anemia in Taiwan [J].Am J Hematol, 2005(78) : 108-122.
  • 3Dubsky P, sevelda P, Jakesz R, et al.Anemia is a significant prognos- tic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/5-fluo- rouracil chemotherapy[J]. Clin Cacer Res, 2008, 14:2082-2087.
  • 4Caro JJ, Salas M, Ward A, et al.Anaemia as an independent prognos- tic factor for survival in patients with cancer:a systemic, quantitative review[J].Cancer, 2001, 91 (12) : 2214-2221.
  • 5Ho CH, Yu YB, Wu PH.The prevalence of iron deficiency anemia and its clinical implications in patients with colorectal carcinoma [J]. J Chin Med Assoc, 2008(71 ) : 119-122.
  • 6李睿,于观贞,王喜,潘军,王杰军.肿瘤相关贫血、肿瘤病理状况与胃癌患者生存预后的相关性研究[J].临床肿瘤学杂志,2008,13(8):704-708. 被引量:13
  • 7Hedenus M, Vansteenkiste J, Kotasek D, et al.Dabepoetin alfa for the treatment of chemotherapy-induced anemia:disease progression and survival analysis from 4 randomized, doable blind placebo-controlled trials[J].J Clin Oncol, 2005 (23) : 6941-6948.
  • 8Van Hilten JA, Van de Velde CJH.Authors " reply:Leucocyte deple- tion of perioperative blood transfusion does not affect long-term sur- vivaland recurrence in patients with gastrointestinal cancer [J].Br J Surg, 2009, 96(7 ) : 734-740.

二级参考文献22

  • 1Caro JJ, Salas M, Ward A, et al. Anemia as an independent prognostic factor for survival in patients with cancer: A systemic, quantitative review[J]. Cancer,2001,91 (12) : 2214 -2221.
  • 2Glaser CM, Millesi W, Kornek GV, et al. Impact of hemoglobin level and use of recombinant erythropoietin on efficacy of preoperative chemoradiation therapy for squamous cell carcinoma of the oral cavity and oropharynx [ J]. Int J Radiat Oncol Biol Phys, 2001,50( 3 ) :705 - 715.
  • 3Grogan M, Thomas GM, Melamed I, et al. The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix [J]. Cancer, 1999, 86(8) :1528 - 1536.
  • 4Lee WR, Berkey B, Marcial V, et al. Anemia is associated with decreased survival and increased locoregional failure in patients with locally advanced head and neck carcinoma: A secondary analysis of RTOG 85-27 [ J ]. Int J Radiat Oncol Biol Phys, 1998, 42 (5) : 1069 - 1075.
  • 5Maestu I, Pastor M, Gomez-Codina J, et al. Pretreatment prognostic factors for survival in small-cell lung cancer: A new prognostic index and validation of three known prognostic indices on 341 patients[J]. AnnOncol, 1997, 8(6) :547 -553.
  • 6Moullet I, Salles G, Ketterer N, et al. Frequency and significance of anemia in non-Hodgkin's lymphoma patients [J]. Ann Oncol, 1998, 9(10) :1109 - 1115.
  • 7Munstedt K, Kovacic M, Zygmunt M, et al. Impact of hemoglobin levels before and during chemotherapy on survival of patients with ovarian cancer[J]. Int J Oncol, 2003, 23 (3) :837 - 843.
  • 8Shasha D. The negative impact of anemia on radiotherapy and chemoradiation outcomes[J]. Semin Hematol, 2001, 38 (3 Suppl 7) :8 - 15.
  • 9Michael H, Johan V, Dusan K, et al. Darbepoetin alfa for the treatment of chemotherapy-induced anemia: disease progression and survival analysis from four randomized, double-blind, placebo-controlled trials [ J]. J Clin Oncol, 2005, 23 ( 28 ) : 6941 - 6948.
  • 10Osterborg A, Brandberg Y, Molostova V, et al. Randomized, double-blind, placebo-controlled trial of recombinant human erythropoietin, epoetin beta, in hematologic malignancies[J]. J Clin Oncol, 2002, 20(10) : 2486 -2494.

共引文献12

同被引文献8

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部